Noriyuki Miyoshi Selected Research

Noriyuki Miyoshi Research Topics

Disease

14	Neoplasms (Cancer) 06/2022 - 03/2002
12	Carcinogenesis 01/2021 - 01/2004
9	Inflammation (Inflammations) 02/2021 - 04/2004
6	Atherosclerosis 01/2020 - 01/2011
6	Obesity 05/2018 - 10/2011
5	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2019
5	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2018 - 01/2011
4	Carcinoma (Carcinomatosis) 01/2021 - 10/2011
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 03/2018
3	Alzheimer Disease (Alzheimer's Disease) 05/2018 - 09/2011
3	Leukemia 01/2012 - 04/2002
3	Necrosis 10/2008 - 03/2002
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 02/2021 - 09/2014
2	Body Weight (Weight, Body) 01/2021 - 06/2011
2	Colonic Neoplasms (Colon Cancer) 08/2017 - 10/2012
2	Hepatocellular Carcinoma (Hepatoma) 09/2011 - 04/2011
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Lymphatic Metastasis 02/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Adenocarcinoma 11/2020
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Warts (Wart) 06/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Infections 01/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2020
1	Hearing Loss (Hearing Impairment) 01/2020
1	Hyperplasia 01/2019
1	Hemorrhage 01/2019
1	Memory Disorders (Memory Loss) 05/2018
1	Parkinson Disease (Parkinson's Disease) 05/2018
1	Cognitive Dysfunction 05/2018
1	Dehydration (Water Stress) 03/2018
1	Lewy Body Disease (Lewy Body Dementia) 03/2018
1	Aberrant Crypt Foci 08/2017
1	Intestinal Polyps 02/2016
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2016

Drug/Important Bio-Agent (IBA)

12	TeaIBA 06/2022 - 07/2008
6	colibactinIBA 03/2022 - 01/2019
5	CholesterolIBA 03/2018 - 01/2011
4	secosterol-BIBA 03/2018 - 01/2011
4	benzyl isothiocyanateIBA 01/2012 - 03/2002
3	Coffee FDA Link 06/2022 - 10/2020
3	Apolipoproteins E (ApoE)IBA 01/2021 - 11/2019
3	ApolipoproteinsIBA 01/2021 - 11/2019
3	2-toluidine (o-toluidine)IBA 12/2020 - 01/2019
3	AldehydesIBA 03/2018 - 01/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2017 - 11/2010
3	EnzymesIBA 09/2012 - 04/2011
2	PolyphenolsIBA 06/2022 - 03/2022
2	MicroRNAs (MicroRNA)IBA 06/2022 - 03/2022
2	QuercetinIBA 02/2021 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2016
2	DNA AdductsIBA 01/2021 - 01/2020
2	2-anisidine (o-anisidine)IBA 01/2021 - 01/2019
2	AminesIBA 01/2021 - 01/2020
2	AcetyltransferasesIBA 01/2021 - 01/2020
2	Catechin (Z 7300)IBA 06/2020 - 04/2011
2	Biological ProductsIBA 01/2020 - 04/2004
2	AcidsIBA 01/2020 - 12/2004
2	Proteins (Proteins, Gene)FDA Link 03/2018 - 11/2010
2	AzoxymethaneIBA 08/2017 - 06/2011
2	isothiocyanic acidIBA 06/2016 - 10/2012
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 07/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 11/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2012 - 01/2012
2	Drinking WaterIBA 09/2012 - 06/2011
2	Oxidants (Oxidizing Agents)IBA 07/2011 - 07/2008
2	CytokinesIBA 06/2011 - 02/2006
2	CaspasesIBA 10/2008 - 03/2002
2	DNA (Deoxyribonucleic Acid)IBA 07/2008 - 12/2004
2	Caspase 3 (Caspase-3)IBA 09/2003 - 03/2002
1	Indicators and Reagents (Reagents)IBA 02/2021
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 01/2021
1	Hemolysin Proteins (Hemolysins)IBA 11/2020
1	Chlorogenic AcidIBA 10/2020
1	stercobilinIBA 01/2020
1	CarcinogensIBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	MutagensIBA 01/2020
1	OligosaccharidesIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	DystrophinIBA 01/2020
1	Volatile Organic CompoundsIBA 01/2020
1	PrebioticsIBA 01/2020
1	PolyketidesIBA 01/2020
1	LipidsIBA 11/2019
1	MyokinesIBA 11/2019
1	Apoptosis Regulatory ProteinsIBA 05/2018
1	SynucleinsIBA 05/2018
1	ScleroproteinsIBA 05/2018
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2018
1	phenethyl isothiocyanate (PEITC)IBA 01/2018
1	LeptinIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 08/2017
1	LuciferasesIBA 08/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2017
1	Anticarcinogenic AgentsIBA 08/2017

Therapy/Procedure

1	Transplantation 01/2020